Johnson & Johnson

Pharmaceuticals / Personal Products / Medical Equipment
JNJ
$ 183 0.15
Share price
$ 480 bn
Market Cap
$ 476 bn
Enterprise Value

Carbon footprint

1.6 Ton
GHG emissions per $ 1 mln investment
0.05x the weighted average for S&P 500
FY2020
How is this calculated?
-20%
YOY change in GHG emissions
Stronger than the -8.7% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

-3.7%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -5.1% weighted average for S&P 500
FY2021
How is this calculated?

Johnson & Johnson aims to reduce Scope 1 + 2 by 60% by 2030 from a base year 2016


1.5°C
Johnson & Johnson's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Johnson & Johnson's GHG emissions (market-based) (Kt of CO2e)
Johnson & Johnson's Carbon intensity (Tons per 1 USDm)

Johnson & Johnson's carbon footprint

Johnson & Johnson reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 748 Kt (-186 /-19.9% y-o-y). Also positively, carbon intensity dropped to 9.1 t (-2.3 /-20.2% y-o-y).

Johnson & Johnson's Scope 3 emissions declined marginally to 20,373 Kt (-128 /-0.6% y-o-y). The time series has been volatile over the last few periods.

The company is committed to reducing Scope 1 + 2 by 60% by 2030 from a base year 2016, which translates into the estimated reduction of -28 Kt per annum over the period of FY2021 - FY2030. This science-based target is aligned with Paris Agreement to limit global warming to 1.5°C above pre-industrial levels.

Company environmental metrics

Show more...